Cytomegalovirus inhibiting compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514215, 540580, 546113, 546122, 546123, A61K 31435, C07D47104

Patent

active

059454318

ABSTRACT:
The present invention relates to heterocyclic compounds having antiviral activity. In particular, compounds of formula (I): wherein B, W, X, Y, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and n are as defined herein, are useful in the therapy and prophylaxis of cytomegalovirus (CMV) infection in mammals.

REFERENCES:
patent: 4786644 (1988-11-01), Glamkowski et al.
patent: 4959363 (1990-09-01), Wentland
Peakdale's Fine Chemicals, 1995 Collection, pp. 1-38.
Peakdale's Fine Chemicals, 1994 Collection, pp. 1-41.
Peakdale's Fine Chemicals: Chemical Family 122 (PFC's 798-803); Chemical Family 123 (PFC's 804-813); and Chemical Family 124 (PFC's 814-819), respectively (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cytomegalovirus inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytomegalovirus inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytomegalovirus inhibiting compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2426592

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.